Clinical and Vaccine Immunology · 2011 · 26 citations · 23 references
Life SciencesImmunologyInfectious DiseasesImmunizationVaccine ImmunologyVaccinologyAdjuvant DevelopmentHumoral ImmunityVaccine DeliveryVaccine PlatformsViral HepatitisViral VaccinesAdjuvant MechanismsAdjuvant UseFilamentous FormHepatitis B Surface Antigen ClearanceHepatitis Virus VaccinationTherapeutic Hepatitis B VaccinesTransgenic MiceVaccine-induced Antibody Responses
A hepatitis B virus (HBV) vaccine has been developed using a new adjuvant and HBV surface antigens produced from a CHO cell line. The purified HBV surface antigens are composed of L protein, M protein, and S protein in a mixture of 20- and 40-nm-diameter particles and filamentous forms. This HBV surface antigen, formulated with L-pampo, a proprietary adjuvant, induced 10 times more antibody than the same antigen with alum and was capable of inducing strong immune responses in three different HBV transgenic mice. In spite of the presence of a large amount of HBV antigen in the blood, no antibody against HBV surface antigen was normally detected in these transgenic mice. After immunization, the HBV antigen was also cleared from the blood.
23
Mohammad Panahi, Mohammad Naderi, Taghavi Seyed Morteza et al. · 2007 · 1.7K citations
Intracellular Inactivation of the Hepatitis B Virus by Cytotoxic T Lymphocytes
Luca G. Guidotti, Tetsuya Ishikawa, M V Hobbs et al. · Immunity · 1996 · 1.1K citations · Full text
Large surface proteins of hepatitis B virus containing the pre-s sequence
K.‐H. Heermann, U Goldmann, W Schwartz et al. · Journal of Virology · 1984 · 820 citations · Full text
Enhanced Immunogenicity of the Pre-S Region of Hepatitis B Surface Antigen
David R. Milich, George B. Thornton, A. R. Neurath et al. · Science · 1985 · 326 citations